- Country profiles
- Data dashboard
- Satellite Pages
- About us
- WHAT'S NEW
Viet Nam has committed to working towards the elimination of HIV mother-to-child transmission. The stated goals are to reduce the vertical transmission rate of HIV nationally to less than 5% by 2015 and to less than 2% by 2020.
Viet Nam has high hepatitis B virus (HBV) and low HIV and syphilis prevalence among pregnant women. Antenatal care (ANC) coverage is high (one visit 96,6%, three visits 87.5%)*. Prevention of mother-to-child-transmission (PMTCT) of HIV and infant hepatitis B immunization are managed by separate vertical programmes and services. It is national policy that free provider-initiated universal HIV testing is recommended to pregnant women (PW). Syphilis and hepatitis B testing are not routinely offered. This study aims at demonstrating an innovative model of combined universal screening for HIV, syphilis, and HBV for PW and treatment of infected PW in ANC to prevent vertical transmission of three infections.
A survey was conducted in countries in all six WHO regions and focused on the building blocks that are considered prerequisites to combat antimicrobial resistance: a comprehensive national plan, laboratory capacity to undertake surveillance for resistant microorganisms, access to safe, effective antimicrobial medicines, control of the misuse of these medicines, awareness and understanding among the general public and effective infection prevention and control programmes.
The present document aims to review the progress of the HIV response in the Asia-Pacific region, with a view to identifying the opportunities for further action afforded by the 2011 Political Declaration. In doing so, it also draws on the expressed commitments undertaken by ESCAP member States to address the HIV epidemic, including those reflected in resolutions 66/10, Regional call for action to achieve universal access to HIV prevention, treatment, care and support in Asia and the Pacific (19 May 2010) and 67/9, Asia-Pacific regional review of the progress achieved in realizing the Declaration of Commitment on HIV/AIDS and the Political Declaration on HIV/AIDS (25 May 2011).
Keywords: IGM, 2015, HIV, prevalence, treatment, care, prevention, gender, violence, ART, children, women
The 10 case studies presented in this document clearly demonstrate that social protection works for HIV prevention, treatment, care and support. In particular, they show how social protection benefits the AIDS response through increased access to HIV services for all people including the most marginalized and excluded in society. The studies also demonstrate that carefully constructed and well-managed social protection programmes have the power to support people who are hardest to reach.
This document presents experiences of how community-based antiretroviral therapy (ART) delivery can improve both the level of access to treatment and the quality of health outcomes for people living with HIV. These experiences illustrate that community-based ART delivery is efficient, effective and high quality.
This report describes the current continuum of testing for HCV, which is complex and expensive, which means that it is very challenging to implement in resource-limited settings. It examines the platforms/tests that are currently available across the range of required HCV testing from screening to confirmation and genotyping, fibrosis staging and treatment monitoring. The report also considers how the testing cascade for HCV may be simplified with the availability of DAAs, which would help make HCV testing attainable in resource-limited settings. Finally, it looks at the pipeline of tests/platforms for HCV that could be delivered at or near the point of patient care.
Keywords: HIV, HCV, treatment, testing, monitoring
Selected policies on adolescent friendly health services in low and middle income countries - information from countries that responded to the Global Maternal, Newborn, Child and Adolescent Health Policy Indicator Surveys (2009-10, 2011-12 and 2013-14) undertaken by Department of Maternal, Newborn, Child and Adolescent Health; World Health
|Download Data Sheet|
Surveillance of transmitted HIV drug resistance (TDR) in individuals recently infected with HIV was performed following WHO-suggested methods. The prevalence of transmitted HIV drug resistance (TDR) in recently infected antiretroviral drug naïve individuals in PNG has not been fully characterised.
UNAIDS welcomes additional evidence released in May 2015 that early initiation of antiretroviral therapy has a positive effect on the health and well-being of people living with HIV. The United States National Institutes of Health-funded international randomized clinical trial START (Strategic Timing of Antiretroviral Treatment) has found compelling evidence that the benefits of starting antiretroviral therapy as soon as someone is diagnosed outweigh the risks of delaying until their CD4 count has fallen to 350 cells/mm3.
This landscape analysis surveys the current state of technologies for the treatment of hepatitis C virus (HCV), as well as market dynamics that affect the affordability and accessibility of HCV therapeutics. HCV treatment falls within the ambit of UNITAID’s mission because it is a major HIV coinfection and a leading cause of morbidity and mortality among people living with HIV. Strategic Objective 3 of the UNITAID Strategy 2013−2016 specifically refers to viral hepatitis, notably hepatitis B and C.